vs
BALCHEM CORP（BCPC）与EOG资源（GURE）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是EOG资源的29.1倍（$263.6M vs $9.0M）。BALCHEM CORP净利率更高（14.9% vs -394.3%，领先409.2%）。EOG资源同比增速更快（303.4% vs 9.8%）。过去两年EOG资源的营收复合增速更高（14.7% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
EOG资源是一家美国能源企业，主营业务为油气勘探开发。公司注册于特拉华州，总部位于德克萨斯州休斯顿的传统广场大厦，是美国本土重要的独立油气生产商之一。
BCPC vs GURE — 直观对比
营收规模更大
BCPC
是对方的29.1倍
$9.0M
营收增速更快
GURE
高出293.5%
9.8%
净利率更高
BCPC
高出409.2%
-394.3%
两年增速更快
GURE
近两年复合增速
4.9%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $9.0M |
| 净利润 | $39.2M | $-35.7M |
| 毛利率 | 35.6% | — |
| 营业利润率 | 19.8% | -3.7% |
| 净利率 | 14.9% | -394.3% |
| 营收同比 | 9.8% | 303.4% |
| 净利润同比 | 16.8% | -921.1% |
| 每股收益（稀释后） | $1.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCGURE
| Q4 25 | $263.6M | — | ||
| Q3 25 | $267.6M | $9.0M | ||
| Q2 25 | $255.5M | $8.3M | ||
| Q1 25 | $250.5M | $1.6M | ||
| Q4 24 | $240.0M | $1.7M | ||
| Q3 24 | $239.9M | $2.2M | ||
| Q2 24 | $234.1M | $2.4M | ||
| Q1 24 | $239.7M | $1.3M |
净利润BCPCGURE
| Q4 25 | $39.2M | — | ||
| Q3 25 | $40.3M | $-35.7M | ||
| Q2 25 | $38.3M | $-773.8K | ||
| Q1 25 | $37.1M | $-4.6M | ||
| Q4 24 | $33.6M | $-18.4M | ||
| Q3 24 | $33.8M | $-3.5M | ||
| Q2 24 | $32.1M | $-33.1M | ||
| Q1 24 | $29.0M | $-4.0M |
毛利率BCPCGURE
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | -114.5% | ||
| Q1 24 | 34.0% | -62.2% |
营业利润率BCPCGURE
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | -3.7% | ||
| Q2 25 | 20.1% | -9.0% | ||
| Q1 25 | 20.4% | -287.3% | ||
| Q4 24 | 19.8% | -363.7% | ||
| Q3 24 | 20.0% | -204.3% | ||
| Q2 24 | 19.6% | -216.0% | ||
| Q1 24 | 17.4% | -403.1% |
净利率BCPCGURE
| Q4 25 | 14.9% | — | ||
| Q3 25 | 15.1% | -394.3% | ||
| Q2 25 | 15.0% | -9.3% | ||
| Q1 25 | 14.8% | -288.5% | ||
| Q4 24 | 14.0% | -1061.8% | ||
| Q3 24 | 14.1% | -155.8% | ||
| Q2 24 | 13.7% | -1388.8% | ||
| Q1 24 | 12.1% | -305.4% |
每股收益（稀释后）BCPCGURE
| Q4 25 | $1.21 | — | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — | ||
| Q1 24 | $0.89 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $107.5M |
| 总资产 | $1.7B | $131.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCGURE
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | $11.2M | ||
| Q2 24 | $63.7M | — | ||
| Q1 24 | $60.3M | — |
股东权益BCPCGURE
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $107.5M | ||
| Q2 25 | $1.3B | $142.2M | ||
| Q1 25 | $1.2B | $142.6M | ||
| Q4 24 | $1.1B | $143.7M | ||
| Q3 24 | $1.2B | $166.5M | ||
| Q2 24 | $1.1B | $166.9M | ||
| Q1 24 | $1.1B | $200.9M |
总资产BCPCGURE
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $131.9M | ||
| Q2 25 | $1.7B | $164.6M | ||
| Q1 25 | $1.6B | $165.7M | ||
| Q4 24 | $1.6B | $169.5M | ||
| Q3 24 | $1.6B | $193.9M | ||
| Q2 24 | $1.6B | $193.9M | ||
| Q1 24 | $1.6B | $221.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $6.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCGURE
| Q4 25 | $67.3M | — | ||
| Q3 25 | $65.6M | $6.7M | ||
| Q2 25 | $47.3M | $-559.3K | ||
| Q1 25 | $36.5M | $-1.6M | ||
| Q4 24 | $52.3M | $968.5K | ||
| Q3 24 | $51.3M | $518.7K | ||
| Q2 24 | $45.0M | $518.3K | ||
| Q1 24 | $33.4M | $-1.3M |
资本支出强度BCPCGURE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率BCPCGURE
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
GURE
| Bromine | $8.1M | 89% |
| Shandong Shouguang Shenrunfa Marine Chemical Company Limited | $1.4M | 15% |
